Premium
Sertraline in the treatment of anxiety disorders
Author(s) -
Hirschfeld Robert M.A.
Publication year - 2000
Publication title -
depression and anxiety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.634
H-Index - 129
eISSN - 1520-6394
pISSN - 1091-4269
DOI - 10.1002/1520-6394(2000)11:4<139::aid-da1>3.0.co;2-c
Subject(s) - sertraline , anxiety , panic disorder , psychiatry , depression (economics) , panic , psychology , anxiety disorder , social anxiety , generalized anxiety disorder , clinical psychology , medicine , antidepressant , economics , macroeconomics
Sertraline was first developed and approved for the treatment of depression. However, considerable research has been conducted on its use in anxiety disorders. This paper reviews the data emerging from controlled and open trials of the use of sertraline in anxiety disorders. Sertraline has been tested extensively in the treatment of panic and obsessive‐compulsive disorders. Less extensive testing has been completed on social phobia and post‐traumatic stress disorder. The reviewed studies show that sertraline is an effective and well‐tolerated treatment of all of these disorders. A comparison of sertraline with other pharmacotherapeutic options shows it to be at least equivalent to other medications for anxiety disorders. Depression and Anxiety 11:139–157, 2000. © 2000 Wiley‐Liss, Inc.